Mass General Hospital develops clinical decision support tool for mpox diagnosis

FHS
April 5, 2024
7:02 pm

Diagnosing infectious conditions can be challenging. Diagnosis is especially challenging for uncommon and emerging infectious diseases for which there’s limited clinical experience.

Nouscom raises $72m in Series C financing round to develop cancer vaccines – Pharmaceutical Technology

Share this article The company has several cancer vaccines in the pipeline, with some in clinical trials. Credit: wildpixel via Getty Images. Swiss biotech Nouscom

November 14, 2023

Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023 – Biotech Investments

EQS-News: Rentschler Biopharma SE / Key word(s): Regulatory Approval Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023 06.03.2024 / 10:00 CET/CEST

March 7, 2024

A preview of Intra-Cellular Therapies’ depression drug, and sizing up the MASH opportunity

I am one week away from the launch of my weekly email newsletter! It’s called Adam’s Biotech Scorecard, and it’s exclusively for STAT subscribers. One

March 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.